Arrowhead Pharmaceuticals News

Latest Arrowhead Pharmaceuticals Stock News & ARWR Headlines

94,000 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR Bought by ACT Capital Partners L.P.

11 hours ago | defenseworld.net

Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2026 Earnings Call Transcript

3 days ago | seekingalpha.com

Arrowhead Pharmaceuticals Q4 Earnings Call Highlights

3 days ago | marketbeat.com

Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conferences

6 days ago | businesswire.com

Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates

8 days ago | businesswire.com

Arrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity

12 days ago | businesswire.com

Arrowhead Pharmaceuticals to Present Important Clinical Data at the American Heart Association Scientific Sessions 2026

14 days ago | businesswire.com

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript

a month ago | seekingalpha.com

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Breaks Below 200 Day Moving Average – Here’s Why

a month ago | defenseworld.net

$Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher$

Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher

a month ago | seekingalpha.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

ARWR

Arrowhead Pharmaceuticals

$ 47.78

1.34%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Arrowhead Pharmaceuticals News

Latest Arrowhead Pharmaceuticals Stock News & ARWR Headlines

Download App

People Also Watch

Explore our Tools